Results 171 to 180 of about 84,355 (327)

Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development

International Journal of Dermatology, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease, with a rising incidence in the elderly. BP is associated with multiple triggering factors, including drug exposure. However, evidence in this respect is limited, and the underlying immune mechanisms remain unknown.
Belen de Nicolas‐Ruanes, Carlos Fernandez‐Lozano, Patricia Gutierrez‐Canales, Asuncion Ballester‐Martinez, Natalia Rodriguez‐Otero, Javier Martinez‐Botas, Belén de la Hoz Caballer, Ana Andres‐Martin, Emilio Solano‐Solares, Maria Esther Gomez‐Salazar Lopez‐Silanes, Laura Gisella Diaz‐Montalvo, Diana M. Arrebola, Vivian Lizeth Stewart‐Delcid, Emilio Garcia‐Mouronte, Carlos Azcarraga‐Llobet, Emilio Berna‐Rico, Sonia Ortega‐Sanchez, Montserrat Fernandez‐Guarino   +17 more
wiley   +1 more source

What Is New in Cutaneous T Cell Lymphoma? [PDF]

Curr Oncol Rep, 2023
Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E.   +4 more
europepmc   +1 more source

Immunopathological study of adult T cell leukemia/lymphoma and cutaneous T cell lymphoma

, 1987
Takahiro Tokudome
openalex   +2 more sources

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review

International Journal of Dermatology, EarlyView.
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Ioannis‐Alexios Koumprentziotis, Aikaterini Niforou, Antonios Tsimpidakis, Christos Nikolaou, Alexander Stratigos, Vasiliki Nikolaou   +5 more
wiley   +1 more source

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma. [PDF]

Blood Adv
Özistanbullu D, Wilhelm R, Reichenbach G, Doll M, Bahrami K, Zöller N, Schnütgen F, König A, Scheller T, Winkler L, Spahn P, Jäger M, Nicolay JP, Pfeilschifter J, Schilling B, Kaufmann R, Koch A, Kippenberger S, Kleemann J, Meissner M.   +19 more
europepmc   +1 more source

Symposium on cutaneous T-cell lymphoma

, 1986
Eric C. Vonderheid, Bizhan Micaily
openalex   +1 more source

p53 and bcl‐2 expression do not correlate with prognosis in primary cutaneous large T‐cell lymphomas [PDF]

, 1997
C.W. van Haselen, Maarten H. Vermeer, Johan Toonstra, S. C. J. van der Putte, Paul Mulder, W.A. van Vloten, Rein Willemze   +6 more
openalex   +1 more source

Primary cutaneous CD8‐positive aggressive epidermotropic cytotoxic T‐cell lymphoma initially demonstrating near‐complete metabolic response to BV‐CHEP

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Tristen Tze Wei Ng, Aaron James Frederiks, Jean‐Frank Iacobelli, Hun Sheng Chuah, Dejan Radeski, Thomas Anthony Delaney   +5 more
wiley   +1 more source

METTL3 Promotes Cutaneous T-Cell Lymphoma Progression by Regulating ARHGEF12 Expression. [PDF]

Int J Mol Sci
Gan L, Kong Y, Shi H, Zhang C, Tian C, Chen H.   +5 more
europepmc   +1 more source

HOXC4, HOXC5, and HOXC6 Expression in Non-Hodgkin's Lymphoma: Preferential Expression of the HOXC5 Gene in Primary Cutaneous Anaplastic T-Cell and Oro-Gastrointestinal Tract Mucosa-Associated B-Cell Lymphomas [PDF]

, 1997
Janet J. Bijl, J W van Oostveen, Jan M.M. Walboomers, A Horstman, Adriaan J. C. van den Brule, Rein Willemze, Chris J.L.M. Meijer   +6 more
openalex   +1 more source